CAR-T Therapy in Haematological Malignancy Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR-T Therapy in Haematological Malignancy Market

1.3 Market Segment by Type

1.3.1 China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Allogeneic from 2016 to 2027

1.3.2 China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Autologous from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Hospitals from 2016 to 2027

1.4.2 China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027

1.4.3 China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Others from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of CAR-T Therapy in Haematological Malignancy by Major Types

3.4.1 Market Size and Growth Rate of Allogeneic

3.4.2 Market Size and Growth Rate of Autologous

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of CAR-T Therapy in Haematological Malignancy by Major End-Users

4.4.1 Market Size and Growth Rate of CAR-T Therapy in Haematological Malignancy in Hospitals

4.4.2 Market Size and Growth Rate of CAR-T Therapy in Haematological Malignancy in Cancer Research Centers

4.4.3 Market Size and Growth Rate of CAR-T Therapy in Haematological Malignancy in Others

5.1 China CAR-T Therapy in Haematological Malignancy Production Analysis by Regions

5.2 China CAR-T Therapy in Haematological Malignancy Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

6.2 North China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

7.1 Central China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

7.2 Central China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

8.1 South China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

8.2 South China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

9.1 East China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

9.2 East China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

10.1 Northeast China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

10.2 Northeast China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

11.1 Southwest China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

11.2 Southwest China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

12.1 Northwest China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major Types

12.2 Northwest China CAR-T Therapy in Haematological Malignancy Landscape Analysis by Major End-Users

13.1 Autolus Therapeutics

13.2 Pfizer

13.3 CARsgen Therapeutics

13.4 Celyad

13.5 Allogene Therapeutics

13.6 Novartis

13.7 Sorrento Therapeutics

13.8 Aurora BioPharma

13.9 Gilead (Kite Pharma)

13.10 Collectis

13.11 Mustang Bio

13.12 Bluebird Bio

13.13 Celgene (Juno Therapeutics)

Figure Product Picture

Figure China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Allogeneic from 2016 to 2027

Figure China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Autologous from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Hospitals from 2016 to 2027

Figure China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027

Figure China CAR-T Therapy in Haematological Malignancy Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of CAR-T Therapy in Haematological Malignancy Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of CAR-T Therapy in Haematological Malignancy

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of CAR-T Therapy in Haematological Malignancy by Different Types from 2016 to 2027

Table Consumption Share of CAR-T Therapy in Haematological Malignancy by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of Allogeneic

Figure Market Size and Growth Rate of Autologous

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of CAR-T Therapy in Haematological Malignancy by Different End-Users from 2016 to 2027

Table Consumption Share of CAR-T Therapy in Haematological Malignancy by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Hospitals

Figure Market Size and Growth Rate of Cancer Research Centers

Figure Market Size and Growth Rate of Others

Table China CAR-T Therapy in Haematological Malignancy Production by Regions

Table China CAR-T Therapy in Haematological Malignancy Production Share by Regions

Figure China CAR-T Therapy in Haematological Malignancy Production Share by Regions in 2016

Figure China CAR-T Therapy in Haematological Malignancy Production Share by Regions in 2021

Figure China CAR-T Therapy in Haematological Malignancy Production Share by Regions in 2027

Table China CAR-T Therapy in Haematological Malignancy Consumption by Regions

Table China CAR-T Therapy in Haematological Malignancy Consumption Share by Regions

Figure China CAR-T Therapy in Haematological Malignancy Consumption Share by Regions in 2016

Figure China CAR-T Therapy in Haematological Malignancy Consumption Share by Regions in 2021

Figure China CAR-T Therapy in Haematological Malignancy Consumption Share by Regions in 2027

Table North China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table North China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table North China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table North China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure North China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table Central China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table Central China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table Central China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table Central China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure Central China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table South China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table South China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table South China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table South China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure South China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table East China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table East China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table East China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table East China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure East China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table Northeast China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table Northeast China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure Northeast China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table Southwest China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table Southwest China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure Southwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table Northwest China CAR-T Therapy in Haematological Malignancy Consumption by Types from 2016 to 2027

Table Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types from 2016 to 2027

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2016

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2021

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by Types in 2027

Table Northwest China CAR-T Therapy in Haematological Malignancy Consumption by End-Users from 2016 to 2027

Table Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users from 2016 to 2027

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2016

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2021

Figure Northwest China CAR-T Therapy in Haematological Malignancy Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Autolus Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics

Figure Sales and Growth Rate Analysis of Autolus Therapeutics

Figure Revenue and Market Share Analysis of Autolus Therapeutics

Table Product and Service Introduction of Autolus Therapeutics

Table Company Profile and Development Status of Pfizer

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

Figure Sales and Growth Rate Analysis of Pfizer

Figure Revenue and Market Share Analysis of Pfizer

Table Product and Service Introduction of Pfizer

Table Company Profile and Development Status of CARsgen Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics

Figure Sales and Growth Rate Analysis of CARsgen Therapeutics

Figure Revenue and Market Share Analysis of CARsgen Therapeutics

Table Product and Service Introduction of CARsgen Therapeutics

Table Company Profile and Development Status of Celyad

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celyad

Figure Sales and Growth Rate Analysis of Celyad

Figure Revenue and Market Share Analysis of Celyad

Table Product and Service Introduction of Celyad

Table Company Profile and Development Status of Allogene Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allogene Therapeutics

Figure Sales and Growth Rate Analysis of Allogene Therapeutics

Figure Revenue and Market Share Analysis of Allogene Therapeutics

Table Product and Service Introduction of Allogene Therapeutics

Table Company Profile and Development Status of Novartis

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

Figure Sales and Growth Rate Analysis of Novartis

Figure Revenue and Market Share Analysis of Novartis

Table Product and Service Introduction of Novartis

Table Company Profile and Development Status of Sorrento Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics

Figure Sales and Growth Rate Analysis of Sorrento Therapeutics

Figure Revenue and Market Share Analysis of Sorrento Therapeutics

Table Product and Service Introduction of Sorrento Therapeutics

Table Company Profile and Development Status of Aurora BioPharma

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora BioPharma

Figure Sales and Growth Rate Analysis of Aurora BioPharma

Figure Revenue and Market Share Analysis of Aurora BioPharma

Table Product and Service Introduction of Aurora BioPharma

Table Company Profile and Development Status of Gilead (Kite Pharma)

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead (Kite Pharma)

Figure Sales and Growth Rate Analysis of Gilead (Kite Pharma)

Figure Revenue and Market Share Analysis of Gilead (Kite Pharma)

Table Product and Service Introduction of Gilead (Kite Pharma)

Table Company Profile and Development Status of Collectis

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Collectis

Figure Sales and Growth Rate Analysis of Collectis

Figure Revenue and Market Share Analysis of Collectis

Table Product and Service Introduction of Collectis

Table Company Profile and Development Status of Mustang Bio

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mustang Bio

Figure Sales and Growth Rate Analysis of Mustang Bio

Figure Revenue and Market Share Analysis of Mustang Bio

Table Product and Service Introduction of Mustang Bio

Table Company Profile and Development Status of Bluebird Bio

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio

Figure Sales and Growth Rate Analysis of Bluebird Bio

Figure Revenue and Market Share Analysis of Bluebird Bio

Table Product and Service Introduction of Bluebird Bio

Table Company Profile and Development Status of Celgene (Juno Therapeutics)

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene (Juno Therapeutics)

Figure Sales and Growth Rate Analysis of Celgene (Juno Therapeutics)

Figure Revenue and Market Share Analysis of Celgene (Juno Therapeutics)

Table Product and Service Introduction of Celgene (Juno Therapeutics)